Applying Evidence-Based Care to Low-Risk Thyroid Cancer

By
Lia D. Delaney
Carolyn D. Seib
October 30, 2026

Jama Network Open

At a Glance

Category	Detail
Condition	Low-risk differentiated thyroid cancer
Key Mechanisms	The article addresses evidence-to-practice barriers in surgical de-escalation, including established surgical habits, professional identity, individualized decision-making, and variation in practice environments.
Target Population	Patients with low-risk differentiated thyroid cancer, including appropriately selected patients with tumors smaller than 4 cm and no nodal metastases or other high-risk features.
Care Setting	Surgical practices and the broader care pathway involving surgeons, referring physicians, and other care-team members.

Key Highlights

Guidelines increasingly endorse thyroid lobectomy for appropriately selected patients with low-risk differentiated thyroid cancer.
For tumors smaller than 4 cm without nodal metastases or other high-risk features, evidence shows comparable oncologic outcomes with lobectomy and total thyroidectomy.
Total thyroidectomy is associated with greater complication risk, lifelong thyroid hormone replacement, and poorer quality of life relative to lobectomy.
In a focused ethnographic study, surgeons most frequently favored performance feedback, but no single intervention was identified as optimal.
Care de-escalation includes decisions about surgery, postoperative radioactive iodine, and long-term surveillance.

Guideline-Based Recommendations

Diagnosis

The article describes treatment selection for low-risk differentiated thyroid cancer but does not provide diagnostic recommendations.

Management

Consider thyroid lobectomy for appropriately selected patients, including those with tumors smaller than 4 cm and no nodal metastases or other high-risk features.
Total thyroidectomy remains an appropriate and safe option for some patients, depending on disease characteristics and patient preferences.
Evidence supports surveillance without postoperative radioactive iodine ablation for most patients.
Coordinate expectations for the initial procedure, adjuvant treatment, and long-term surveillance across the care team.

Monitoring & Follow-up

The article identifies long-term surveillance as part of less-intensive management but does not specify a surveillance schedule.

Risks

Compared with lobectomy, total thyroidectomy is associated with greater risk of complications, including transient or permanent hypoparathyroidism.
Total thyroidectomy necessitates lifelong thyroid hormone replacement and is linked to poorer quality of life.
The article notes that treatment variation is expected; the objective is to reduce variation not explained by relevant clinical or patient factors.

Patient & Prescribing Data

Patients with low-risk differentiated thyroid cancer; the article cites tumors smaller than 4 cm without nodal metastases or other high-risk features as a group for whom lobectomy may be appropriate.

Total thyroidectomy remains the treatment for approximately 60% to 80% of patients with low-risk thyroid cancer. The article supports individualized decisions about lobectomy, total thyroidectomy, postoperative radioactive iodine, and surveillance.

Clinical Best Practices

Use relevant disease characteristics and patient preferences when selecting the extent of surgery.
Consider performance feedback, such as comparison of surgeons’ total thyroidectomy rates with those of peers, as a possible practice-change strategy; the article does not identify a single optimal intervention.
Develop decision-support tools collaboratively with surgeons and tailor them to local workflows, resources, and patient populations.
Engage referring physicians and other care-team members in aligning expectations about surgery, adjuvant treatment, and surveillance.